# Induction FLOT With CROSS CRT for Esophageal Cancer

> **NCT04028167** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 40 (estimated)

## Conditions studied

- Adenocarcinoma Esophagus
- Adenocarcinoma of the Gastroesophageal Junction

## Interventions

- **DRUG:** Sequential FLOT followed by chemoradiation

## Key facts

- **NCT ID:** NCT04028167
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-04-08
- **Primary completion:** 2026-01-02
- **Final completion:** 2027-04-19
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04028167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04028167, "Induction FLOT With CROSS CRT for Esophageal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04028167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*